Home › Funds › Sofinnova Investments, Inc. › ABT

Sofinnova Investments, Inc. position in ABT

ABBOTT LABORATORIES · Health Care

Sofinnova Investments, Inc. reported holding 207,000 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$20.5M, representing 0.92% of its reported portfolio and ranking #24 among its reported holdings. Sofinnova Investments, Inc. has disclosed ABT holdings in 3 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)207.00K sh
Reported value held$20.46M
Portfolio Weight0.92%
First reportedQ2 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s ABT position evolved

Sofinnova Investments, Inc. first disclosed a stake in ABT in Q2 2024 at 390,200 shares (US$40.5M). Across 3 filings, Sofinnova Investments, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 207,000 shares valued at US$20.5M — an increase of 84,002 shares quarter over quarter.. Notable position changes include a 68% increase in Q3 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 390.20K $40.55M New
Q2 2026 123.00K $11.16M New
Q3 2026 207.00K $20.46M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Sofinnova Investments, Inc. held ABT?

Sofinnova Investments, Inc. has disclosed ABT holdings in 3 of the last 10 reported quarters, going back to Q2 2024.

What is Sofinnova Investments, Inc.'s current position in ABT?

As of Q3 2026, Sofinnova Investments, Inc. holds 207.00K shares of ABT (ABBOTT LABORATORIES), valued at $20.46M, representing 0.92% of its reported portfolio and ranking #24.

Has Sofinnova Investments, Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), Sofinnova Investments, Inc. increased its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.